{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T02:59:02Z","timestamp":1784343542284,"version":"3.55.0"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010198","name":"Ministerio de Econom\u00eda, Industria y Competitividad, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2020.00309","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T04:22:23Z","timestamp":1582777343000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":41,"title":["Clinical Relevance and Molecular Pathogenesis of the Emerging Serotypes 22F and 33F of Streptococcus pneumoniae in Spain"],"prefix":"10.3389","volume":"11","author":[{"given":"Julio","family":"Sempere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"de Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Gonz\u00e1lez-Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Yuste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirian","family":"Domenech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1093\/infdis\/jiz034","article-title":"Pneumococcal colonization in healthy adult research participants in the conjugate vaccine era, United Kingdom, 2010-2017.","volume":"219","author":"Adler","year":"2019","journal-title":"J. Infect. Dis."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137565","article-title":"Emergence of amoxicillin-resistant variants of Spain9V-ST156 pneumococci expressing serotype 11A correlates with their ability to evade the host immune response.","volume":"10","author":"Aguinagalde","year":"2015","journal-title":"PLoS One"},{"key":"B3","doi-asserted-by":"publisher","first-page":"6802","DOI":"10.1016\/j.vaccine.2012.09.019","article-title":"Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales.","volume":"30","author":"Andrews","year":"2012","journal-title":"Vaccine"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.3201\/eid2011.131215","article-title":"Spread of Streptococcus pneumoniae serotype 8-ST63 multidrug-resistant recombinant Clone, Spain.","volume":"20","author":"Ardanuy","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e204","DOI":"10.1016\/S1473-3099(17)30478-4","article-title":"Use of mathematical modelling to assess the impact of vaccines on antibiotic resistance.","volume":"18","author":"Atkins","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007438","article-title":"Global emergence and population dynamics of divergent serotype 3 CC180 pneumococci.","volume":"14","author":"Azarian","year":"2018","journal-title":"PLoS Pathog."},{"key":"B7","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jinf.2018.06.004","article-title":"The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: a systematic review and meta-analysis.","volume":"77","author":"Balsells","year":"2018","journal-title":"J. Infect."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177113","article-title":"Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: a systematic review and meta-analysis.","volume":"12","author":"Balsells","year":"2017","journal-title":"PLoS One"},{"key":"B9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","article-title":"Streptococcus pneumoniae colonisation: the key to pneumococcal disease.","volume":"4","author":"Bogaert","year":"2004","journal-title":"Lancet Infect. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.","volume":"372","author":"Bonten","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0030168","article-title":"Vaccine escape recombinants emerge after pneumococcal vaccination in the United States.","volume":"3","author":"Brueggemann","year":"2007","journal-title":"PLoS Pathog."},{"key":"B12","doi-asserted-by":"publisher","first-page":"4966","DOI":"10.1128\/jcm.41.11.4966-4970.2003","article-title":"Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates.","volume":"41","author":"Brueggemann","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0208211","article-title":"Expansion of the multidrug-resistant clonal complex 320 among invasive Streptococcus pneumoniae serotype 19A after the introduction of a ten-valent pneumococcal conjugate vaccine in Brazil.","volume":"13","author":"Cassiolato","year":"2018","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz404","article-title":"Early signals of vaccine driven perturbation seen in pneumococcal carriage population genomic data.","author":"Chaguza","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1128\/CVI.00591-15","article-title":"Capsular polysaccharide release by serotype 3 pneumococcal strains reduces the protective effect of anti-type 3 capsular antibodies.","volume":"23","author":"Choi","year":"2015","journal-title":"Clin. Vaccine Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21645515.2016.1277300","article-title":"Pneumococcal serotype distribution: a snapshot of recent data in pediatric and adult populations around the world.","volume":"13","author":"Cui","year":"2017","journal-title":"Hum. Vaccin Immunother."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/fty073","article-title":"Hyperencapsulated mucoid pneumococcal isolates from patients with cystic fibrosis have increased biofilm density and persistence in vivo.","volume":"76","author":"Dennis","year":"2018","journal-title":"Pathog. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1111\/1462-2920.12370","article-title":"In vitro biofilm formation by Streptococcus pneumoniae as a predictor of post-vaccination emerging serotypes colonizing the human nasopharynx.","volume":"16","author":"Domenech","year":"2014","journal-title":"Environ. Microbiol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125636","article-title":"Emerging, non-PCV13 serotypes 11A and 35B of Streptococcus pneumoniae show high potential for biofilm formation in vitro.","volume":"10","author":"Domenech","year":"2015","journal-title":"PLoS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1111\/j.1462-2920.2009.01979.x","article-title":"Versatility of the capsular genes during biofilm formation by Streptococcus pneumoniae.","volume":"11","author":"Domenech","year":"2009","journal-title":"Environ. Microbiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1128\/IAI.00491-13","article-title":"Biofilm formation avoids complement immunity and phagocytosis of Streptococcus pneumoniae.","volume":"81","author":"Domenech","year":"2013","journal-title":"Infect. Immun."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02700","article-title":"Combination of antibodies and antibiotics as a promising strategy against multidrug-resistant pathogens of the respiratory tract.","volume":"9","author":"Domenech","year":"2018","journal-title":"Front. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1128\/cmr.15.2.167-193.2002","article-title":"Biofilms: survival mechanisms of clinically relevant microorganisms.","volume":"15","author":"Donlan","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"key":"B24","year":"2018","journal-title":"Invasive Pneumococcal Disease-Annual Epidemiological Report for 2016."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020390","article-title":"Population structure of invasive Streptococcus pneumoniae in the Netherlands in the pre-vaccination era assessed by MLVA and capsular sequence typing.","volume":"6","author":"Elberse","year":"2011","journal-title":"PLoS One"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001517","article-title":"Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites.","volume":"10","author":"Feikin","year":"2013","journal-title":"PLoS Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1128\/jb.186.5.1518-1530.2004","article-title":"eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data.","volume":"186","author":"Feil","year":"2004","journal-title":"J. Bacteriol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.1016\/j.vaccine.2015.08.009","article-title":"Secular trends (1990-2013) in serotypes and associated non-susceptibility of S. pneumoniae isolates causing invasive disease in the pre-\/post-era of pneumococcal conjugate vaccines in Spanish regions without universal paediatric pneumococcal vaccination.","volume":"33","author":"Fenoll","year":"2015","journal-title":"Vaccine"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the global burden of disease study 2016.","volume":"18","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1128\/CMR.00024-15","article-title":"Pneumococcal capsules and their types: past, present, and future.","volume":"28","author":"Geno","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"vii20","DOI":"10.1093\/jac\/dky157","article-title":"Molecular characterization of predominant Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-15.","author":"Golden","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1016\/j.vaccine.2016.03.058","article-title":"Invasive Streptococcus pneumoniae in Canada, 2011-2014: characterization of new candidate 15-valent pneumococcal conjugate vaccine serotypes 22F and 33F.","volume":"34","author":"Golden","year":"2016","journal-title":"Vaccine"},{"key":"B33","doi-asserted-by":"publisher","first-page":"6883","DOI":"10.1016\/j.vaccine.2018.02.113","article-title":"Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants.","volume":"36","author":"Greenberg","year":"2018","journal-title":"Vaccine"},{"key":"B34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1503\/cmaj.080734","article-title":"Efficacy of pneumococcal vaccination in adults: a meta-analysis.","volume":"180","author":"Huss","year":"2009","journal-title":"CMAJ"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024581","article-title":"Effects of Streptococcus pneumoniae strain background on complement resistance.","volume":"6","author":"Hyams","year":"2011","journal-title":"PLoS One"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02096-18","article-title":"Efficacy of aminomethyl spectinomycins against complex upper respiratory tract bacterial infections.","volume":"63","author":"Iverson","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B37","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/INF.0b013e318275614b","article-title":"Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine.","volume":"32","author":"Kaplan","year":"2013","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B38","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","article-title":"Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study.","volume":"18","author":"Ladhani","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e213","DOI":"10.1016\/S1473-3099(18)30660-1","article-title":"Making sense of differences in pneumococcal serotype replacement.","volume":"19","author":"Lewnard","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S1473-3099(16)00054-2","article-title":"Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study.","volume":"16","author":"Mackenzie","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.1128\/IAI.05663-11","article-title":"Contribution of serotype and genetic background to virulence of serotype 3 and serogroup 11 pneumococcal isolates.","volume":"79","author":"McAllister","year":"2011","journal-title":"Infect. Immun."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1093\/cid\/ciy312","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccine against hospitalization for community-acquired pneumonia in older us adults: a test-negative design.","volume":"67","author":"McLaughlin","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"5264","DOI":"10.1016\/j.vaccine.2017.08.007","article-title":"The burden of PCV13 serotypes in hospitalized pneumococcal pneumonia in Spain using a novel urinary antigen detection test. CAPA study.","volume":"35","author":"Men\u00e9ndez","year":"2017","journal-title":"Vaccine"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1084\/jem.188.11.2047","article-title":"Characterization of the galU gene of Streptococcus pneumoniae encoding a uridine diphosphoglucose pyrophosphorylase: a gene essential for capsular polysaccharide biosynthesis.","volume":"188","author":"Mollerach","year":"1998","journal-title":"J. Exp. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/s1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance.","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2018.00145","article-title":"Purification of capsular polysaccharides of Streptococcus pneumoniae: traditional and new methods.","volume":"6","author":"Morais","year":"2018","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"7785","DOI":"10.1128\/JB.00673-06","article-title":"Biofilm formation by Streptococcus pneumoniae: role of choline, extracellular DNA, and capsular polysaccharide in microbial accretion.","volume":"188","author":"Moscoso","year":"2006","journal-title":"J. Bacteriol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1172\/JCI36759","article-title":"Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models.","volume":"119","author":"Orihuela","year":"2009","journal-title":"J. Clin. Invest."},{"key":"B49","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1128\/JCM.01917-12","article-title":"Changes in molecular epidemiology of Streptococcus pneumoniae causing meningitis following introduction of pneumococcal conjugate vaccination in England and Wales.","volume":"51","author":"Pichon","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005500","article-title":"PSGL-1 on leukocytes is a critical component of the host immune response against invasive pneumococcal disease.","volume":"12","author":"Ramos-Sevillano","year":"2016","journal-title":"PLoS Pathog."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1016\/j.vaccine.2018.03.001","article-title":"Long-term impact of 10-valent pneumococcal conjugate vaccination on invasive pneumococcal disease among children in Finland.","volume":"36","author":"Rinta-Kokko","year":"2018","journal-title":"Vaccine"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.vaccine.2014.12.058","article-title":"Lack of effectiveness of the 23-valent polysaccharide pneumococcal vaccine in reducing all-cause pneumonias among healthy young military recruits: a randomized, double-blind, placebo-controlled trial.","volume":"33","author":"Russell","year":"2015","journal-title":"Vaccine"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1128\/JCM.01763-10","article-title":"Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype.","volume":"49","author":"Sa-Leao","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/S2213-2600(17)30110-8","article-title":"Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study.","volume":"5","author":"Savulescu","year":"2017","journal-title":"Lancet Respir. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.2147\/IDR.S165093","article-title":"Overview of pneumococcal serotypes and genotypes causing diseases in patients with chronic obstructive pulmonary disease in a Spanish hospital between 2013 and 2016.","volume":"11","author":"Shoji","year":"2018","journal-title":"Infect. Drug Resist."},{"key":"B56","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1080\/1040841X.2019.1660616","article-title":"Otitis media pathogens \u2013 A life entrapped in biofilm communities.","volume":"45","author":"Silva","year":"2019","journal-title":"Crit. Rev. Microbiol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1080\/21645515.2018.1532249","article-title":"Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults.","volume":"15","author":"Stacey","year":"2019","journal-title":"Hum. Vaccin Immunother."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.4049\/jimmunol.0900688","article-title":"Human neutrophils kill Streptococcus pneumoniae via serine proteases.","volume":"183","author":"Standish","year":"2009","journal-title":"J. Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"6201","DOI":"10.1016\/j.vaccine.2019.08.048","article-title":"Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults.","volume":"37","author":"Thompson","year":"2019","journal-title":"Vaccine"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177985","article-title":"Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies.","volume":"12","author":"Tin Tin Htar","year":"2017","journal-title":"PLoS One"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/S0140-6736(09)61114-4","article-title":"Pathogenesis, treatment, and prevention of pneumococcal pneumonia.","volume":"374","author":"van der Poll","year":"2009","journal-title":"Lancet"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039150","article-title":"Effect of serotype on focus and mortality of invasive pneumococcal disease: coverage of different vaccines and insight into non-vaccine serotypes.","volume":"7","author":"van Hoek","year":"2012","journal-title":"PLoS One"},{"key":"B63","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ijantimicag.2014.05.016","article-title":"Characterisation of a collection of Streptococcus pneumoniae isolates from patients suffering from acute exacerbations of chronic bronchitis: in vitro susceptibility to antibiotics and biofilm formation in relation to antibiotic efflux and serotypes\/serogroups.","volume":"44","author":"Vandevelde","year":"2014","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1128\/IAI.01096-12","article-title":"Quorum-sensing systems LuxS\/autoinducer 2 and Com regulate Streptococcus pneumoniae biofilms in a bioreactor with living cultures of human respiratory cells.","volume":"81","author":"Vidal","year":"2013","journal-title":"Infect. Immun."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","article-title":"Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15.","volume":"6","author":"Wahl","year":"2018","journal-title":"Lancet Glob. Health"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000476","article-title":"Pneumococcal capsular polysaccharide structure predicts serotype prevalence.","volume":"5","author":"Weinberger","year":"2009","journal-title":"PLoS Pathog."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.00953-17","article-title":"Competitive dominance within biofilm consortia regulates the relative distribution of pneumococcal nasopharyngeal density.","volume":"83","author":"Wu","year":"2017","journal-title":"Appl. Environ. Microbiol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.vaccine.2010.10.032","article-title":"Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease.","volume":"29","author":"Yildirim","year":"2010","journal-title":"Vaccine"},{"key":"B69","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1128\/IAI.00541-09","article-title":"The effects of PspC on complement-mediated immunity to Streptococcus pneumoniae vary with strain background and capsular serotype.","volume":"78","author":"Yuste","year":"2010","journal-title":"Infect. Immun."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.00309\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T04:22:25Z","timestamp":1582777345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.00309\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,27]]},"references-count":69,"alternative-id":["10.3389\/fmicb.2020.00309"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2020.00309","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,27]]},"article-number":"309"}}